James D. Brooks

Active 1985–2025

179
Papers
18,643
Citations
76
h-index
155
i10-index

Citations

Citations per year for James D. Brooks1986: 1 citations1987: 4 citations1988: 1 citations1989: 5 citations1990: 4 citations1992: 2 citations1993: 2 citations1994: 4 citations1995: 27 citations1996: 35 citations1997: 52 citations1998: 49 citations1999: 66 citations2000: 57 citations2001: 90 citations2002: 102 citations2003: 121 citations2004: 158 citations2005: 197 citations2006: 170 citations2007: 164 citations2008: 157 citations2009: 159 citations2010: 141 citations2011: 132 citations2012: 156 citations2013: 149 citations2014: 160 citations2015: 135 citations2016: 136 citations2017: 120 citations2018: 142 citations2019: 410 citations2020: 451 citations2021: 555 citations2022: 461 citations2023: 403 citations2024: 614 citations2025: 255 citations2026: 19 citations1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,837 citing papers, 34.2% of this breakdownChina: 900 citing papers, 10.9% of this breakdownUnited Kingdom: 534 citing papers, 6.5% of this breakdownGermany: 389 citing papers, 4.7% of this breakdownCanada: 358 citing papers, 4.3% of this breakdownItaly: 298 citing papers, 3.6% of this breakdownNetherlands: 227 citing papers, 2.7% of this breakdownAustralia: 203 citing papers, 2.5% of this breakdownFrance: 202 citing papers, 2.4% of this breakdownJapan: 201 citing papers, 2.4% of this breakdownSpain: 169 citing papers, 2% of this breakdownIndia: 145 citing papers, 1.8% of this breakdown
0%34.2%Other 22%

Fields

  • Medicine43.5%
  • Biochemistry, Genetics and Molecular Biology41.6%
  • Computer Science3.1%
  • Engineering2.3%
  • Chemistry1.7%
  • Immunology and Microbiology1.6%
  • Other6.2%

Topics

  • Prostate Cancer Treatment and Research6%
  • Epigenetics and DNA Methylation4.8%
  • Prostate Cancer Diagnosis and Treatment4.7%
  • Renal cell carcinoma treatment2.9%
  • RNA modifications and cancer2.4%
  • Cancer Genomics and Diagnostics2.3%
  • Other76.9%

Coauthors

All papers

Open in search
  1. The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M Snyder, Peter K. Sorger, Avrum Spira, Sudhir Srivastava, Kai Tan, Robert B. West, Elizabeth H. Williams, Denise R. Aberle, Samuel I. Achilefu, Foluso O. Ademuyiwa, Andrew Adey, Rebecca Aft, Rachana Agarwal, Ruben A. Aguilar, Fatemeh Alikarami‬, Viola Allaj, Christopher I. Amos, Robert A. Anders, Michael Angelo, Kristen Anton, Orr Ashenberg, Jon C. Aster, Özgün Babur, Amir Bahmani, Akshay Balsubramani, David Barrett, Jennifer Beane, Diane E. Bender, Kathrin M. Bernt, Lynne D. Berry, Courtney B. Betts, Julie Bletz, Katie E. Blise, Adrienne Boire, Genevieve M. Boland, Alexander Borowsky, Kristopher R. Bosse, Matthew J. Bott, Ed Boyden, James D. Brooks, Raphael Bueno, Erik A. Burlingame, Qiuyin Cai, Joshua D. Campbell, Wagma Caravan, Ethan Cerami, Hassan Chaı̈b, Joseph M. Chan, Young Hwan Chang, Deyali Chatterjee, Ojasvi Chaudhary, Alyce A. Chen, Bob Chen, Changya Chen, Chia‐Hui Chen, Feng Chen, Yuan Chen, Milan G. Chheda, Koei Chin, Roxanne Chiu, Shih‐Kai Chu, Rodrigo Chuaqui, Jaeyoung Chun, Luis Cisneros, Robert J. Coffey, Graham A. Colditz, Kristina A. Cole, Natalie B. Collins, Kévin Contrepois, Lisa M. Coussens and 294 more - Cell 2020 cited by 615

  2. Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer

    Authors: , , , , , , , , - Cancer Research 2021 cited by 303

  3. A review of artificial intelligence in prostate cancer detection on imaging

    Authors: , , , , , , , , , , , , - Therapeutic Advances in Urology 2022 cited by 70

  4. Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape

    Authors: , , , , , , , - Genome biology 2013 cited by 381

  5. Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists

    Authors: , , , , , , , , , - European Urology Focus 2017 cited by 278

  6. The m 6 A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 102

  7. Mutations of the VHL tumour suppressor gene in renal carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 1994 cited by 1,741

  8. Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1

    Authors: , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 143

  9. Oncogene-mediated metabolic gene signature predicts breast cancer outcome

    Authors: , , , , , , , , , , , , , - npj Breast Cancer 2021 cited by 63

  10. Selective identification and localization of indolent and aggressive prostate cancers via CorrSigNIA: an MRI-pathology correlation and deep learning framework

    Authors: , , , , , , , , , , , , - Medical Image Analysis, Medical Image Anal. 2021 cited by 59

  11. 3D Registration of pre-surgical prostate MRI and histopathology images via super-resolution volume reconstruction

    Authors: , , , , , , , , , , , , - Medical Image Analysis, Medical Image Anal. 2021 cited by 52

  12. Effect of automation transparency in the management of multiple unmanned vehicles

    Authors: , , , , , , , - Applied Ergonomics 2020 cited by 50

  13. Automated detection of aggressive and indolent prostate cancer on magnetic resonance imaging

    Authors: , , , , , , , , , , , , , - Medical Physics 2021 cited by 54

  14. Simultaneous transrectal ultrasound and photoacoustic human prostate imaging

    Authors: , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2019 cited by 136

  15. Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 209

  16. Gene expression profiling identifies clinically relevant subtypes of prostate cancer

    Authors: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 1,307

  17. PlexusNet: A neural network architectural concept for medical image classification

    Authors: , , , , , , - Computers in Biology and Medicine, Comput. Biol. Medicine 2023 cited by 21

  18. Trends in incidence and 5‐year mortality in men with newly diagnosed, metastatic prostate cancer—A population‐based analysis of 2 national cohorts

    Authors: , , , , , , , , - Cancer 2018 cited by 103

  19. Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - JAMA 2024 cited by 63

  20. Increased Risk of Cancer in Infertile Men: Analysis of U.S. Claims Data

    Authors: , , , , - The Journal of Urology 2014 cited by 168

  21. Deficiency in Mammalian Histone H2B Ubiquitin Ligase Bre1 (Rnf20/Rnf40) Leads to Replication Stress and Chromosomal Instability

    Authors: , , , , , , , , , , , - Cancer Research 2012 cited by 141

  22. S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma

    Authors: , , , , , , , , , , , , , - Cancer Research 2019 cited by 60

  23. Weakly supervised natural language processing for assessing patient-centered outcome following prostate cancer treatment

    Authors: , , , , , , , - JAMIA Open 2019 cited by 51

  24. Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study

    Authors: , , , , , , , - European Urology 2023 cited by 41